| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
249,725 | 249,130 | 240,978 | 216,187 | 219,080 |
| Cost of Revenue
|
-89,382 | -90,860 | -90,108 | -82,937 | -85,387 |
|
Gross Profit
|
160,343 | 158,270 | 150,870 | 133,250 | 133,693 |
| Selling, General and Administrative Expenses
|
-117,816 | -119,451 | -115,016 | -111,492 | -109,883 |
|
Research and Development Expenses
|
-20,049 | -20,308 | -19,518 | -19,300 | -20,490 |
|
Operating Income/Expenses
|
-137,865 | -139,759 | -134,534 | -130,792 | -130,373 |
|
Total Operating Profit/Loss
|
22,478 | 18,511 | 16,336 | 2,458 | 3,320 |
| Total Net Finance Income/Expense
|
-10,857 | -10,692 | -11,859 | -5,697 | -4,770 |
| Irregular Income/Expenses
|
0 | 0 | 2,887 | -274,533 | 0 |
|
Other Income/Expense, Non-Operating
|
-2,266 | 4,195 | -1,403 | 2,124 | 1,061 |
|
Non-Operating Income/Expenses, Total
|
-13,123 | -6,497 | -10,375 | -278,106 | -3,709 |
|
Pretax Income
|
9,355 | 12,014 | 5,961 | -275,648 | -389 |
|
Provision for Income Tax
|
-4,555 | -5,302 | -7,935 | 21,402 | 1,319 |
|
Net Income from Continuing Operations
|
4,800 | 6,712 | -1,974 | -254,246 | 930 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
4,800 | 6,712 | -1,974 | -254,246 | 930 |
|
Net Income after Non-Controlling/Minority Interests
|
4,800 | 6,712 | -1,974 | -254,246 | 930 |
|
Net Income Available to Common Stockholders
|
4,800 | 6,712 | -1,974 | -254,246 | 930 |
|
Diluted Net Income Available to Common Stockholders
|
4,800 | 6,712 | -1,974 | -254,246 | 930 |
|
Common Dividend per Share
|
0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Basic EPS
|
0.86 | 1.22 | -0.36 | -47.20 | 0.17 |
| Diluted EPS
|
0.84 | 1.21 | -0.36 | -47.20 | 0.17 |
|
Basic Weighted Average Shares Outstanding
|
5,562 | 5,514 | 5,421 | 5,386 | 5,321 |
|
Diluted Weighted Average Shares Outstanding
|
5,616 | 5,565 | 5,421 | 5,386 | 5,361 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
20,212 | 22,706 | 17,820 | -269,951 | 4,381 |
|
EBITDA
|
43,171 | 45,977 | 42,347 | -238,377 | 37,515 |
|
Normalized EBITDA
|
59,517 | 63,845 | 52,602 | 165,733 | 50,053 |
|
Normalized Income
|
17,713.34 | 20,827.72 | 6,127.45 | 139,497.84 | 10,835.02 |
|
Total Unusual Items
|
16,346 | 17,868 | 10,255 | 404,110 | 12,538 |
|
Total Unusual Items Excluding Goodwill
|
16,346 | 17,868 | 10,255 | 129,577 | 12,538 |
3/31/2023 - 2/29/1984
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade